Max Higgins, Senior Consultant, Author at EverGlade

Max Higgins, Senior Consultant

Max Higgins, Senior Consultant

ARPA-H’s BRAINS Initiative to Advance Functional Brain Tissue Repair

Download the Solicitation Restoring Brain Function: ARPA-H’s BRAINS Initiative The Advanced Research Projects Agency for Health (ARPA-H) has launched the Brain Repair of Any Injured Neural Structure (BRAINS) initiative to address a major unmet need in neurological care: the lack of effective therapies to replace damaged or degenerated brain tissue and restore lost function. Brain […]

ARPA-H’s BRAINS Initiative to Advance Functional Brain Tissue Repair Read More »

BARDA Seeks Input on Medical Countermeasures for Drug-Resistant Fungal Infections

Download the Solicitation The Biomedical Advanced Research and Development Authority (BARDA), within the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS), has issued a Request for Information (RFI) to better understand the current development landscape for antifungal medical countermeasures. BARDA plays a central role in advancing

BARDA Seeks Input on Medical Countermeasures for Drug-Resistant Fungal Infections Read More »

BARDA Seeks Input on AI-Enabled Discovery of Broad-Spectrum Small-Molecule Filovirus Therapeutics

Download the Solicitation The Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), has issued a Request for Information (RFI) focused on AI-Enabled Discovery of Broad-Spectrum Small-Molecule Inhibitors for Filoviruses. Filoviruses, including Ebola virus (EBOV), Sudan virus

BARDA Seeks Input on AI-Enabled Discovery of Broad-Spectrum Small-Molecule Filovirus Therapeutics Read More »

DARPA Seeks Input on Rapid Petroleum Stabilization and Repurposing Technologies

Download the Solicitation The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), has released a Request for Information (RFI) titled ROUNDTOP, seeking input from industry, academia, government laboratories, and non-traditional performers. The RFI focuses on advanced methods to rapidly stabilize and/or repurpose large volumes of petroleum products, including petroleum abandoned in

DARPA Seeks Input on Rapid Petroleum Stabilization and Repurposing Technologies Read More »

autonomous robotic systems – Untethered Robotics

Materials for Physical Compute in Untethered Robotics

DARPA-SN-26-76 In April 2026, the Defense Advanced Research Projects Agency (DARPA), through its Microsystems Technology Office (MTO), released a Request for Information (RFI) titled “Materials for Physical Compute in Untethered Robotics” (DARPA-SN-26-76). This RFI signals DARPA’s early-stage interest in advancing the next generation of autonomous robotic systems capable of operating in communication-denied and dynamically changing

Materials for Physical Compute in Untethered Robotics Read More »

Organoid Cytomorphic Intelligence Resulting from Convergent Understanding and Information Transfer (O-Circuit)

DARPA’s O-Circuit Program and the Future of Biological Computing

DARPA-PS-26-28 In May 2026, the Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), released a new program solicitation titled Organoid Cytomorphic Intelligence Resulting from Convergent Understanding and Information Transfer (O-Circuit). This initiative reflects DARPA’s continued investment in next-generation computing paradigms, specifically those that move beyond traditional silicon-based systems. At a high

DARPA’s O-Circuit Program and the Future of Biological Computing Read More »

ARPA-H Launches IGoR Program to Transform Biomedical Research Infrastructure

ARPA-H Launches IGoR Program to Transform Biomedical Research Infrastructure

ARPA-H-SOL-26-155 APPENDIX A: PROGRAM AND TECHNICAL DESCRIPTION The Advanced Research Projects Agency for Health (ARPA-H) has released the Intelligent Generator of Research (IGoR) Innovative Solutions Opening (ISO), a bold initiative designed to fundamentally transform how biomedical research is conducted. Managed through ARPA-H’s Proactive Health Office, the program seeks to address longstanding inefficiencies in scientific discovery

ARPA-H Launches IGoR Program to Transform Biomedical Research Infrastructure Read More »

DARPA’s RAPIID Program shelf stable blood analogs

DARPA’s RAPIID Program to Transform Trauma Care with Shelf-Stable Blood Analogs

DARPA-SN-26-77 The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), has issued Special Notice DARPA-SN-26-77 to announce forthcoming areas of interest for the Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) program. As part of DARPA’s broader mission to accelerate breakthrough technologies for national security, this initiative aims to address one of

DARPA’s RAPIID Program to Transform Trauma Care with Shelf-Stable Blood Analogs Read More »

DARPA DICE Program

DARPA’s DICE Program

DARPA-SN-26-65 The Defense Advanced Research Projects Agency (DARPA), through its Information Innovation Office (I2O), has released a Special Notice titled Decentralized Artificial Intelligence through Controlled Emergence (DICE), DARPA-SN-26-65. This notice reflects DARPA’s ongoing mandate to pursue bold, high-impact research that delivers asymmetric advantages for national defense. With DICE, DARPA is targeting one of the most

DARPA’s DICE Program Read More »

ARPA-H TIGAR Biopreservation

ARPA-H TIGAR Opens a New Lane for Biopreservation Innovation

ARPA-H-SOL-26-144_TIGAR ISO ARPA-H’s new Technology InteGrator and AcceleratoR (TIGAR) Innovative Solutions Opening (ISO) is a tightly scoped opportunity for government contractors and their research partners to reshape how complex biologics, tissues, and organs are stored, transported, and deployed at scale. By seeding high-risk, high-impact biopreservation concepts, TIGAR aims to unlock temperature-flexible storage for increasingly large

ARPA-H TIGAR Opens a New Lane for Biopreservation Innovation Read More »

BARDA-BAA-advanced-medical-countermeasures

BARDA’s Modernized BAA: A New On-Ramp for Advanced Medical Countermeasure Development

BARDA_FY23 Modernized BAA Solicitation – Amendment 7 The Biomedical Advanced Research and Development Authority (BARDA) has released its modernized Broad Agency Announcement (BAA-23-100-SOL-00004, Amendment 7), creating a flexible, multi-year pathway for industry to partner with the U.S. Government on advanced medical countermeasures (MCMs) for CBRN, pandemic influenza, and emerging infectious disease threats to the U.S.

BARDA’s Modernized BAA: A New On-Ramp for Advanced Medical Countermeasure Development Read More »

BARDA RRPV RAPID Solicitation Rapid Antibody Production

BARDA’s RRPV 26-10-RAPID Solicitation for Rapid Antibody Production

RRPV-26-10-RAPID The Biomedical Advanced Research and Development Authority (BARDA), through the Rapid Response Partnership Vehicle (RRPV), has released a new Request for Project Proposals (RPP) to stand up U.S.-based rapid antibody and protein binder production platforms that can go from pathogen gene sequence to immunoassay-ready reagents within weeks instead of months. This is a targeted opportunity to position platform

BARDA’s RRPV 26-10-RAPID Solicitation for Rapid Antibody Production Read More »

Scroll to Top